77
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Adverse drug events affecting medication persistence with rivastigmine patch application

, , , &
Pages 1247-1252 | Published online: 18 Jul 2018

References

  • Cabinet Office, Government of JapanWhite paper on the aging society2017 Available from: http://www8.cao.go.jp/kourei/whitepaper/w-2017/zenbun/29pdf_index.htmlAccessed December 20, 2017
  • YamamuraKWatanabeNDisease-Based Pharmacotherapy for Pharmacists, IIJapanese Society of Pharmaceutical Health Care and Sciences20115368
  • Japanese Society of Neurology Guidelines for Dementia Joint CommitteeGuidelines for Dementia 2017: Igaku-Shoin2017
  • UmegakiHItohASuzukiYNabeshimaTDiscontinuation of donepezil for the treatment of Alzheimer’s disease in geriatric practiceInt Psychogeriatr200820480080618341753
  • NozawaAOtaniMAdvantages and disadvantages of transdermally delivered drugs unknowable from package inserts alone: rivastigmineJ Pract Pharm2013641331923197
  • Information for approved drugs in Japan: rivastigmine patch Available from: http://www.info.pmda.go.jp/go/pack/1190700S1029_1_08/Accessed December 26, 2017
  • KurodaAHokonoharaDKuronoAEffectiveness of rivastigmine in Alzheimer’s disease as seen by caregivers: Kagoshima Ninchisho Support (KNS) studyJ New Rem Clin2013621018241831
  • NakamuraKWatanabeNOhkawaHEffects on caregiver burden of a donepezil hydrochloride dosage increase to 10 mg/day in patients with Alzheimer’s diseasePatient Prefer Adherence201415812231228
  • WatanabeNYamamuraKSuzukiYPharmacist-based donepezil outpatient consultation service to improve medication persistencePatient Prefer Adherence2012660561122969291
  • NakamuraYStrohmaierCTamuraKA 24-week, randomized, controlled study to evaluate the tolerability, safety and efficacy of 2 different titration schemes of the rivastigmine patch in Japanese patients with mild to moderate Alzheimer’s diseaseDement Geriatr Cogn Dis Extra20155336137426557135
  • KudoCYamakawaNNakamuraNOne-week consecutive pretreatment of moisturizing agent decreases irritant contact dermatitis by rivastigmine patch in the treatment of Alzheimer’s diseaseJ Jpn Soc Early Stage Dement20136198102
  • IshihamaHSugamataNSeoYEffects of a heparinoid topical spray for Rivastigmine patch-induced skin reactionsProg Med201636129599